| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jan―31 |
Analyzing COVID-19 progression with Markov multistage models: insights from a Korean cohort |
Frank Aimee Rodrigue Ndagijimana, Taesung Park |
| 2 |
[GO] |
2024―May―31 |
Dispersion of SARS-CoV-2 lineage BA.5.1.25 and its descendants in Peru during two COVID-19 waves in 2022 |
Victor Jimenez-Vasquez, Natalia Vargas-Herrera, Luis Bárcena-Flores, Verónica Hurtado, Carlos Padilla-Rojas, Roger V. Araujo-Castillo |
| 3 |
[GO] |
2023―Dec―29 |
An analysis of the waning effect of COVID-19 vaccinations |
Bogyeom Lee, Hanbyul Song, Catherine Apio, Kyulhee Han, Jiwon Park, Zhe Liu, et al. (+2) Hu Xuwen, Taesung Park |
| 4 |
[GO] |
2023―Jun―30 |
COVID-19 progression towards ARDS: a genome wide study reveals host factors underlying critical COVID-19 |
Shama Mujawar, Gayatri Patil, Srushti Suthar, Tanuja Shendkar, Vaishnavi Gangadhar |
| 5 |
[GO] |
2023―Jun―30 |
e-Pharmacophore modeling and in silico study of CD147 receptor against SARS-CoV-2 drugs |
Nisha Kumari Pandit, Simranjeet Singh Mann, Anee Mohanty, Sumer Singh Meena |
| 6 |
[GO] |
2023―Mar―31 |
A network pharmacology and molecular docking approach in the exploratory investigation of the biological mechanisms of lagundi (Vitex negundo L.) compounds against COVID-19 |
Robertson G. Rivera, Patrick Junard S. Regidor, Edwin C. Ruamero Jr, Eric John V. Allanigue, Melanie V. Salinas |
| 7 |
[GO] |
2023―Mar―31 |
A bioinformatics approach to characterize a hypothetical protein Q6S8D9_SARS of SARS-CoV |
Md. Foyzur Rahman, Rubait Hasan, Mohammad Shahangir Biswas, Jamiatul Husna Shathi, Md. Faruk Hossain, Aoulia Yeasmin, et al. (+2) Mohammad Zakerin Abedin, Md. Tofazzal Hossain |
| 8 |
[GO] |
2022―Sep―30 |
A systemic study on the vulnerability and fatality of prostate cancer patients towards COVID-19 through analysis of the TMPRSS2, CXCL10 and their co-expressed genes |
Md. Thosif Raza, Shagufta Mizan |
| 9 |
[GO] |
2022―Sep―30 |
Mining and analysis of microsatellites in human coronavirus genomes using the in-house built Java pipeline |
P. K. Bharti, Akhtar Husai |
| 10 |
[GO] |
2022―Jun―30 |
Mathematical modeling of the impact of Omicron variant on the COVID-19 situation in South Korea |
Jooha Oh, Catherine Apio, Taesung Park |
| 11 |
[GO] |
2021―Dec―31 |
COVID-19 pandemic: Is it the right time to develop interconnected national biomedical registries? |
Athanasios S. Kotoulas |
| 12 |
[GO] |
2021―Dec―31 |
Microsecond molecular dynamics simulations revealed the inhibitory potency of amiloride analogs against SARS-CoV-2 E viroporin |
Abdullah All Jaber, Zeshan Mahmud Chowdhury, Arittra Bhattacharjee, Muntahi Mourin, Chaman Ara Keya, Zaied Ahmed Bhuyan |
| 13 |
[GO] |
2021―Dec―31 |
High-performance computing for SARS-CoV-2 RNAs clustering: a data science-based genomics approach |
Anas Oujja, Mohamed Riduan Abid, Jaouad Boumhidi, Safae Bourhnane, Asmaa Mourhir, Fatima Merchant, Driss Benhaddou |
| 14 |
[GO] |
2021―Sep―30 |
Improving classification of low-resource COVID-19 literature by using Named Entity Recognition |
Oscar Lithgow-Serrano, Joseph Cornelius, Vani Kanjirangat, Carlos-Francisco Méndez-Cruz, Fabio Rinaldi |
| 15 |
[GO] |
2021―Sep―30 |
Constructing Japanese MeSH term dictionaries related to the COVID-19 literature |
Atsuko Yamaguchi, Terue Takatsuki, Yuka Tateisi, Felipe Soares |
| 16 |
[GO] |
2021―Sep―30 |
A biomedically oriented automatically annotated Twitter COVID-19 dataset |
Luis Alberto Robles Hernandez, Tiffany J. Callahan, Juan M. Banda |
| 17 |
[GO] |
2021―Sep―30 |
LitCovid-AGAC: cellular and molecular level annotation data set based on COVID-19 |
Sizhuo Ouyang, Yuxing Wang, Kaiyin Zhou, Jingbo Xia |
| 18 |
[GO] |
2021―Sep―30 |
COVID-19 recommender system based on an annotated multilingual corpus |
Márcia Barros, Pedro Ruas, Diana Sousa, Ali Haider Bangash, Francisco M. Couto |
| 19 |
[GO] |
2021―Jun―30 |
A protein interactions map of multiple organ systems associated with COVID-19 disease |
Dhammapal Bharne |
| 20 |
[GO] |
2021―Jun―30 |
Comparative study: nonsynonymous and synonymous substitution of SARS-CoV-2, SARS-CoV, and MERS-CoV genome |
Vipan Kumar Sohpal |
| 21 |
[GO] |
2021―Mar―31 |
Forecasting of the COVID-19 pandemic situation of Korea |
Taewan Goo, Catherine Apio, Gyujin Heo, Doeun Lee, Jong Hyeok Lee, Jisun Lim, et al. (+2) Kyulhee Han, Taesung Park |
| 22 |
[GO] |
2020―Dec―31 |
Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19 |
Subrata K. Biswas, Sonchita R. Mudi |
| 23 |
[GO] |
2020―Dec―31 |
Updated confidence intervals for the COVID-19 antibody retention rate in the Korean population |
Md. Kamruzzaman, Catherine Apio, Taesung Park |
| 24 |
[GO] |
2020―Dec―31 |
Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2 |
Manisha Ray, Saurav Sarkar, Surya Narayan Rath |
| 25 |
[GO] |
2020―Sep―29 |
Confidence intervals for the COVID-19 neutralizing antibody retention rate in the Korean population |
Catherine Apio, Md. Kamruzzaman, Taesung Park |
| 26 |
[GO] |
2020―Sep―29 |
Computational Analysis of CoV-2, Severe Acute Respiratory Syndrome CoV & Middle East Respiratory Syndrome Genome using MEGA |
Vipan Kumar Sohpal |
